Thomas DesRosier
Direttore/Membro del Consiglio presso AVANIR PHARMACEUTICALS INC
Patrimonio netto: 122 390 $ in data 31/05/2024
Profilo
Thomas J.
DesRosier is currently a Director at Avanir Pharmaceuticals, Inc., a Director at Optimer Pharmaceuticals LLC, and the Secretary, Chief Legal Officer & Executive VP at Seres Therapeutics, Inc. He previously held positions as a Director at Trius Therapeutics, Inc., Assistant General Counsel-Patents at Wyeth LLC, Chief Patent Counsel & Vice President at Genetics Institute LLC, Secretary, Chief Legal & Administrative Officer at ARIAD Pharmaceuticals, Inc., Secretary, Chief Legal & Administrative Officer at Cubist Pharmaceuticals LLC, Chief Legal Officer, SVP & General Counsel at Genzyme Corp., Senior Vice President & General Counsel at Sanofi, Principal at Wyeth Pharmaceuticals LLC, Principal at Lantheus Medical Imaging, Inc., and Principal at Dupont De Nemours & Co., Inc. DesRosier received his undergraduate degree from the University of Vermont and his graduate degree from Wake Forest University School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SERES THERAPEUTICS INC
0.08% | 15/05/2024 | 122 390 ( 0.08% ) | 122 390 $ | 31/05/2024 |
Posizioni attive di Thomas DesRosier
| Società | Posizione | Inizio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Consigliere Generale | 16/05/2016 |
| AVANIR PHARMACEUTICALS INC | Direttore/Membro del Consiglio | - |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Direttore/Membro del Consiglio | 24/10/2013 |
Precedenti posizioni note di Thomas DesRosier
| Società | Posizione | Fine |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Direttore Amministrativo | 01/01/2016 |
| CUBIST PHARMACEUTICALS INC | Direttore Amministrativo | 22/01/2015 |
| SANOFI | Consigliere Generale | 01/01/2013 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Consigliere Generale | 01/01/2011 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Corporate Officer/Principal | - |
Formazione di Thomas DesRosier
| University of Vermont | Undergraduate Degree |
| Wake Forest University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANOFI | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Dupont De Nemours & Co., Inc.
 Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Part of Corteva, Inc., Dupont De Nemours & Co., Inc. is a company that manufactures hybrid corn and soybean seeds. The company is based in Wilmington, DE. | Process Industries |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
- Borsa valori
- Insiders
- Thomas DesRosier
